{"count": 44, "results": [{"_id": "32665866", "pmid": 32665866, "pmcid": "PMC7346111", "title": "A Case of Severe Mitral Valve Regurgitation in a Patient with Leadless Pacemaker", "journal": "Case Rep Cardiol", "authors": ["Gumireddy SR", "Katayama M", "Chaliki HP"], "date": "2020-06-30T00:00:00Z", "doi": "10.1155/2020/5389279", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "5389279", "score": 50247.336, "text_hl": "An 85-year-old man with cardiac history notable for @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ diagnosed 10 years ago which was being treated with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Warfarin @CHEMICAL_MESH:D014859 @@@warfarin@@@ presented to our institution with persistent @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@. ", "citations": {"NLM": "Gumireddy SR, Katayama M, Chaliki HP. A Case of Severe Mitral Valve Regurgitation in a Patient with Leadless Pacemaker Case Rep Cardiol. 2020;2020():5389279. PMID: 32665866", "BibTeX": "@article{32665866, title={A Case of Severe Mitral Valve Regurgitation in a Patient with Leadless Pacemaker}, author={Gumireddy SR and Katayama M and Chaliki HP}, journal={Case Rep Cardiol}, volume={2020}, pages={5389279}}"}}, {"_id": "32586143", "pmid": 32586143, "title": "On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy.", "journal": "Blood Press", "authors": ["Okin PM", "Hille DA", "Wachtell K", "Kjeldsen SE", "Julius S", "Devereux RB"], "date": "2020-10-01T00:00:00Z", "doi": "10.1080/08037051.2020.1782171", "meta_date_publication": "2020 Oct", "meta_volume": "29", "meta_issue": "5", "meta_pages": "319-326", "score": 50242.254, "text_hl": "Whether changing levels of HDL over time are more strongly related to the risk of new @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ has not been examined.Material and methods: Incident @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@ was examined in relation to baseline and on-treatment HDL levels in 8267 @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with no history of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@, in sinus rhythm on their baseline electrocardiogram, randomly assigned to @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@- or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@-based treatment. ", "citations": {"NLM": "Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Julius S, Devereux RB. On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy. Blood Press. 2020 Oct;29(5):319-326. PMID: 32586143", "BibTeX": "@article{32586143, title={On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy.}, author={Okin PM and Hille DA and Wachtell K and Kjeldsen SE and Julius S and Devereux RB}, journal={Blood Press}, volume={29}, number={5}, pages={319-326}}"}}, {"_id": "32124390", "pmid": 32124390, "title": "Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders.", "journal": "Pharmacol Rep", "authors": ["Siwek M", "Woroń J", "Gorostowicz A", "Wordliczek J"], "date": "2020-04-01T00:00:00Z", "doi": "10.1007/s43440-020-00058-6", "meta_date_publication": "2020 Apr", "meta_volume": "72", "meta_issue": "2", "meta_pages": "350-359", "score": 50229.336, "text_hl": "RESULTS: The highest number of interactions with antipsychotics was recorded among beta-blockers (n = 13, 25% of all cases), including @DISEASE_Arrhythmias_Cardiac @DISEASE_MESH:D001145 @@@cardiac arrhythmias@@@ [@<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ (n = 1): @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@ plus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@; @DISEASE_Bradycardia @DISEASE_MESH:D001919 @@@bradycardia@@@ (n = 1): @CHEMICAL_Perphenazine @CHEMICAL_MESH:D010546 @@@perphenazine@@@ with @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@; @DISEASE_Arrhythmias_Cardiac @DISEASE_MESH:D001145 @@@ventricular arrhythmias@@@: @CHEMICAL_sertindole @CHEMICAL_MESH:C066304 @@@sertindole@@@ with @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ (n = 1) and @CHEMICAL_ziprasidone @CHEMICAL_MESH:C092292 @@@ziprasidone@@@ with @CHEMICAL_Sotalol @CHEMICAL_MESH:D013015 @@@sotalol@@@ (n = 3)] and @DISEASE_Hypotension @DISEASE_MESH:D007022 @@@hypotension@@@ [@CHEMICAL_Chlorprothixene @CHEMICAL_MESH:D002749 @@@chlorprotixene@@@ with @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ or @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ (n = 2)]. 12 cases concerned statins-@DISEASE_Myalgia @DISEASE_MESH:D063806 @@@myalgia@@@, @DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@myopathy@@@, or creatine kinase elevation appeared after combination of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ with @CHEMICAL_Haloperidol @CHEMICAL_MESH:D006220 @@@haloperidol@@@ (n = 1), @CHEMICAL_Quetiapine_Fumarate @CHEMICAL_MESH:D000069348 @@@quetiapine@@@ (n = 3) or @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@ (n = 1), and @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ with @CHEMICAL_Quetiapine_Fumarate @CHEMICAL_MESH:D000069348 @@@quetiapine@@@ (n = 5) or @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@ (n = 2). ", "citations": {"NLM": "Siwek M, Woroń J, Gorostowicz A, Wordliczek J. Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders. Pharmacol Rep. 2020 Apr;72(2):350-359. PMID: 32124390", "BibTeX": "@article{32124390, title={Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders.}, author={Siwek M and Woroń J and Gorostowicz A and Wordliczek J}, journal={Pharmacol Rep}, volume={72}, number={2}, pages={350-359}}"}}, {"_id": "7106148", "pmid": 7106148, "title": "Atrial fibrillation induced by atenolol.", "journal": "Eur Heart J", "authors": ["Rasmussen K", "Andersen K", "Wang H"], "date": "1982-06-01T00:00:00Z", "doi": "10.1093/oxfordjournals.eurheartj.a061304", "meta_date_publication": "1982 Jun", "meta_volume": "3", "meta_issue": "3", "meta_pages": "276-81", "score": 50086.605, "text_hl": "@<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@Atrial fibrillation@@@ induced by @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@.", "citations": {"NLM": "Rasmussen K, Andersen K, Wang H. Atrial fibrillation induced by atenolol. Eur Heart J. 1982 Jun;3(3):276-81. PMID: 7106148", "BibTeX": "@article{7106148, title={Atrial fibrillation induced by atenolol.}, author={Rasmussen K and Andersen K and Wang H}, journal={Eur Heart J}, volume={3}, number={3}, pages={276-81}}"}}, {"_id": "25709353", "pmid": 25709353, "pmcid": "PMC4319249", "title": "Recurrence of atrial fibrillation after switching from brand to generic atenolol", "journal": "J Pharmacol Pharmacother", "authors": ["Gallelli L", "Maida F", "Staltari O", "Rende P", "Russo E", "Caroleo B", "De Sarro G"], "date": "2015-01-01T00:00:00Z", "doi": "10.4103/0976-500X.149146", "meta_date_publication": "2015 Jan-Mar", "meta_volume": "6", "meta_issue": "1", "meta_pages": "39-41", "score": 50077.945, "text_hl": "Recurrence of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ after switching from brand to generic @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@", "citations": {"NLM": "Gallelli L, Maida F, Staltari O, Rende P, Russo E, Caroleo B, De Sarro G. Recurrence of atrial fibrillation after switching from brand to generic atenolol J Pharmacol Pharmacother. 2015 Jan-Mar;6(1):39-41. PMID: 25709353", "BibTeX": "@article{25709353, title={Recurrence of atrial fibrillation after switching from brand to generic atenolol}, author={Gallelli L and Maida F and Staltari O and Rende P and Russo E and Caroleo B and De Sarro G}, journal={J Pharmacol Pharmacother}, volume={6}, number={1}, pages={39-41}}"}}, {"_id": "8733316", "pmid": 8733316, "title": "[Comparison between digoxin and atenolol in chronic atrial fibrillation].", "journal": "Rev Med Chil", "authors": ["Lanas F", "Salvatici R", "Castillo G", "Montecinos A", "Stockins B", "Molina E"], "date": "1995-10-01T00:00:00Z", "meta_date_publication": "1995 Oct", "meta_volume": "123", "meta_issue": "10", "meta_pages": "1252-62", "score": 50075.137, "text_hl": "[Comparison between @CHEMICAL_Digoxin @CHEMICAL_MESH:D004077 @@@digoxin@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in chronic @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@].", "citations": {"NLM": "Lanas F, Salvatici R, Castillo G, Montecinos A, Stockins B, Molina E. [Comparison between digoxin and atenolol in chronic atrial fibrillation]. Rev Med Chil. 1995 Oct;123(10):1252-62. PMID: 8733316", "BibTeX": "@article{8733316, title={[Comparison between digoxin and atenolol in chronic atrial fibrillation].}, author={Lanas F and Salvatici R and Castillo G and Montecinos A and Stockins B and Molina E}, journal={Rev Med Chil}, volume={123}, number={10}, pages={1252-62}}"}}, {"_id": "12204730", "pmid": 12204730, "title": "The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence.", "journal": "Eur J Cardiothorac Surg", "authors": ["Yazicioglu L", "Eryilmaz S", "Sirlak M", "Inan MB", "Aral A", "Tasoz R", "Akalin H"], "date": "2002-09-01T00:00:00Z", "doi": "10.1016/s1010-7940(02)00308-1", "meta_date_publication": "2002 Sep", "meta_volume": "22", "meta_issue": "3", "meta_pages": "397-401", "score": 50072.87, "text_hl": "The effect of preoperative digitalis and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ combination on postoperative @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ incidence.", "citations": {"NLM": "Yazicioglu L, Eryilmaz S, Sirlak M, Inan MB, Aral A, Tasoz R, Akalin H. The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence. Eur J Cardiothorac Surg. 2002 Sep;22(3):397-401. PMID: 12204730", "BibTeX": "@article{12204730, title={The effect of preoperative digitalis and atenolol combination on postoperative atrial fibrillation incidence.}, author={Yazicioglu L and Eryilmaz S and Sirlak M and Inan MB and Aral A and Tasoz R and Akalin H}, journal={Eur J Cardiothorac Surg}, volume={22}, number={3}, pages={397-401}}"}}, {"_id": "14992883", "pmid": 14992883, "title": "Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery.", "journal": "Ann Thorac Surg", "authors": ["Sanjuán R", "Blasco M", "Carbonell N", "Jordá A", "Núñez J", "Martínez-León J", "Otero E"], "date": "2004-03-01T00:00:00Z", "doi": "10.1016/j.athoracsur.2003.06.014", "meta_date_publication": "2004 Mar", "meta_volume": "77", "meta_issue": "3", "meta_pages": "838-43", "score": 50068.348, "text_hl": "Preoperative use of @CHEMICAL_Sotalol @CHEMICAL_MESH:D013015 @@@sotalol@@@ versus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ for @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ after cardiac surgery.", "citations": {"NLM": "Sanjuán R, Blasco M, Carbonell N, Jordá A, Núñez J, Martínez-León J, Otero E. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. Ann Thorac Surg. 2004 Mar;77(3):838-43. PMID: 14992883", "BibTeX": "@article{14992883, title={Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery.}, author={Sanjuán R and Blasco M and Carbonell N and Jordá A and Núñez J and Martínez-León J and Otero E}, journal={Ann Thorac Surg}, volume={77}, number={3}, pages={838-43}}"}}, {"_id": "7908532", "pmid": 7908532, "title": "Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.", "journal": "Br J Clin Pharmacol", "authors": ["Channer KS", "James MA", "MacConnell T", "Rees JR"], "date": "1994-01-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1994.tb04238.x", "meta_date_publication": "1994 Jan", "meta_volume": "37", "meta_issue": "1", "meta_pages": "53-7", "score": 50063.74, "text_hl": "We have compared the effect of combining @CHEMICAL_Digoxin @CHEMICAL_MESH:D004077 @@@digoxin@@@ (0.25 mg daily) with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ 50 mg and 100 mg or @CHEMICAL_Pindolol @CHEMICAL_MESH:D010869 @@@pindolol@@@ 5 mg twice daily and 15 mg twice daily in a cross-over randomised single-blind trial in eight symptomatic @SPECIES_9606 @@@patients@@@ (six male; mean age 62 years) with poorly controlled @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@. 2. ", "citations": {"NLM": "Channer KS, James MA, MacConnell T, Rees JR. Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity. Br J Clin Pharmacol. 1994 Jan;37(1):53-7. PMID: 7908532", "BibTeX": "@article{7908532, title={Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.}, author={Channer KS and James MA and MacConnell T and Rees JR}, journal={Br J Clin Pharmacol}, volume={37}, number={1}, pages={53-7}}"}}, {"_id": "17364111", "pmid": 17364111, "title": "Effects of the association of dual-site dynamic atrial overdrive and atenolol in preventing recurrent atrial fibrillation.", "journal": "Arq Bras Cardiol", "authors": ["Menezes Ada S Jr", "Martinelli Filho M", "Menezes CC", "Costa R", "Ramires JA"], "date": "2007-01-01T00:00:00Z", "doi": "10.1590/s0066-782x2007000100001", "meta_date_publication": "2007 Jan", "meta_volume": "88", "meta_issue": "1", "meta_pages": "1-7", "score": 50062.27, "text_hl": "Effects of the association of dual-site dynamic @DISEASE_Atrial_Remodeling @DISEASE_MESH:D064752 @@@atrial overdrive@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in preventing recurrent @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@.", "citations": {"NLM": "Menezes Ada S Jr, Martinelli Filho M, Menezes CC, Costa R, Ramires JA. Effects of the association of dual-site dynamic atrial overdrive and atenolol in preventing recurrent atrial fibrillation. Arq Bras Cardiol. 2007 Jan;88(1):1-7. PMID: 17364111", "BibTeX": "@article{17364111, title={Effects of the association of dual-site dynamic atrial overdrive and atenolol in preventing recurrent atrial fibrillation.}, author={Menezes Ada S Jr and Martinelli Filho M and Menezes CC and Costa R and Ramires JA}, journal={Arq Bras Cardiol}, volume={88}, number={1}, pages={1-7}}"}}]}